Navigation Links
Medarex Announces 2007 Fourth Quarter and Year End Financial Results
Date:2/26/2008

14,128 12,643 3,290 3,132

Gain on sale of Genmab stock 152,143 - - -

Impairment loss on

investments in partners (2,141) (5,170) - (5,170)

Minority interest - Celldex 4,699 6,891 157 2,110

Non-cash gain on loss of

significant influence

in Genmab - 3,202 - -

Loss before provision for

income taxes (27,055) (181,265) (44,818) (57,590)

Provision for income taxes 12 436 5 115

Net loss $(27,067) $(181,701) $(44,823) $(57,705)

Basic and diluted net

loss per share $(0.21) $(1.50) $(0.35) $(0.46)

Weighted average number of

common shares outstanding

during the year - basic and

diluted 126,665 121,126 127,409 124,593

Condensed Consolidated Balance Sheet

(In thousands)

December 31, December 31,

2007 2006

(1)

Cash, cash equivalents and marketable

securities - Medarex $343,862 $325,494

Cash and cash equivalents - Celldex 4,910 14,000

Marketable securities - Genmab 152,000 150,000

Other current assets 29,013 22,271

Property, buildings and equipment, net 79,925 84,341

Marketable securities - Genmab non-current 139,165 -

Investment in Genmab - 344,382

Other assets
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
2. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
3. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
4. Medarex to Present at the JPMorgan Small/Mid Cap Conference
5. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
6. Grupo Casa Saba Announces Fourth Quarter 2007 Results
7. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
8. Reproductive Medicine Associates of Texas Announces Open House in San Antonio
9. WallSt.net (www.WallSt.net) Announces Upcoming Interview With Chairman and CEO of flexSCAN, Inc.
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Thomson Healthcare Announces Enhancements to Order Sets Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... active in almost all types of cancer sends the ... help fuel a tumour,s uncontrolled growth, new research suggests. ... identified a molecular trigger responsible for ratcheting up activity ... that makes the building blocks cancer cells need to ... pathway, called SREBP, controls the flow of messages to ...
(Date:7/9/2014)... of lung cancer, researchers have uncovered mutations in a ... The new knowledge may expand treatments for patients because ... available or are in clinical trials. , Reporting July ... Genome Atlas (TCGA), including researchers at Washington University School ... other institutions, studied tumors from 230 patients with lung ...
(Date:7/9/2014)... Center paint a relatively optimistic picture of women,s chances ... spread to the chest wall or skin, but not ... regardless of size and whether they have involved lymph ... called "locally advanced" tumors, suggesting that they are a ... Locally advanced breast cancers of this and other types ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... and subjective, the human brain turns them into ... different senses, situations and even people, reports a ... , "We discovered that fine-grained patterns of neural ... the brain associated with emotional processing, act as ... feeling," says Anderson, associate professor of human development ...
Breaking Medicine News(10 mins):Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Lung cancer study hints at new treatments 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 2Health News:Fox Chase researchers recommend updating the staging criteria for breast cancer diagnoses 3Health News:BU researchers relate arrests with HIV risk environment 2Health News:Study cracks how the brain processes emotions 2
... use of ovarian tissue cryopreservation and transplantation has lead ... solid tumors, this method of fertility preservation may be ... study published online in Blood , ... method involves removing and freezing ovarian tissue before the ...
... Reporter , FRIDAY, Aug. 13 (HealthDay News) -- When John D,Amato ... bottle of ibuprofen on the living room floor -- and one ... the pain-reliever container off the coffee table -- where D,Amato had ... pills. "My heart dropped through the floor," he said of ...
... been discovered. Variably protease-sensitive prionopathy (VPSPr), as it has ... disease to be identified since Creutzfeldt-Jakob disease (CJD) was ... National Prion Disease Pathology Surveillance Center at Case Western ... Annals of Neurology . Normally, ...
... HealthDay Reporter , THURSDAY, Aug. 12 (HealthDay News) ... never stop worrying about their children,s troubles, even when they,re ... mix of successful and not-so-successful adult children, the heartache they ... feelings from the accomplishments of their other offspring, a new ...
... PITTSBURGHCarnegie Mellon University,s Steinbrenner Institute for Environmental Education ... Braddock, Pa., to retrain local workers to create ... both local economic growth and energy efficiency. ... academic leaders along with a U.S. Labor Department ...
... rare hereditary cancer syndrome may have a role in the regulation ... In the August 15 issue of Genes & Development , ... protein called merlin, encoded by the NF2 (neurofibromatosis type 2) gene, ... the two major types of liver cells. "We found ...
Cached Medicine News:Health News:Technique to preserve fertility in young women may be unsafe for patients with leukemia 2Health News:Technique to preserve fertility in young women may be unsafe for patients with leukemia 3Health News:Human Meds Are Pets' Biggest Poisoning Danger 2Health News:Human Meds Are Pets' Biggest Poisoning Danger 3Health News:New sporadic prion protein disease identified by Case Western Reserve 2Health News:New sporadic prion protein disease identified by Case Western Reserve 3Health News:One Troubled Adult Child a Drag on Parents' Mental Health 2Health News:One Troubled Adult Child a Drag on Parents' Mental Health 3Health News:Carnegie Mellon's Steinbrenner Institute helps grow green jobs 2Health News:Merlin protein found to control liver stem cells, prevent tumor development 2
(Date:1/14/2014)... Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... results for the fourth quarter of 2013 on Monday, February ... for release after the close of trading. ... conference call to discuss the operating highlights and financial results ...
(Date:1/14/2014)... , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s new ... targeting guide with accompanying instrumentation to place and insert ... to the soft tissue (e.g. ligament) repair or reconstruction ... repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... VALHALLA, N.Y. , Jan. 14, 2014   Oligomerix, Inc. ... disease modifying therapeutics for Alzheimer,s disease (AD) and related ... headquarters to Valhalla, NY as ... additional laboratory space at New York Medical College. ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... Calif., Dec. 7, 2010 Anthera Pharmaceuticals, Inc. (Nasdaq: ... to treat serious diseases associated with inflammation, today announced ... 2010 European Society Pediatric Research Award at the Third ... in Copenhagen, Denmark where Dr. Daniele De Luca, MD, ...
... 2010 Alder Biopharmaceuticals Inc. today announced that data ... antibody therapeutic that targets interleukin-6 (IL-6) demonstrate a reversal ... cancer (NSCLC). After 12 weeks of treatment ... received ALD518 experienced hemoglobin level increases from less than ...
Cached Medicine Technology:Varespladib Receives 2010 European Society Pediatric Research Award 2Varespladib Receives 2010 European Society Pediatric Research Award 3Data from Phase 2 Study of Alder Biopharmaceuticals' Anti-IL-6 Antibody Therapeutic, ALD518, Demonstrate Reversal of Anemia in Patients with Advanced Non-Small Cell Lung Cancer 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: